CN112043771A - Combustible moxibustion column capable of killing viruses - Google Patents
Combustible moxibustion column capable of killing viruses Download PDFInfo
- Publication number
- CN112043771A CN112043771A CN202010818411.7A CN202010818411A CN112043771A CN 112043771 A CN112043771 A CN 112043771A CN 202010818411 A CN202010818411 A CN 202010818411A CN 112043771 A CN112043771 A CN 112043771A
- Authority
- CN
- China
- Prior art keywords
- combustible
- moxibustion column
- moxibustion
- realgar
- viruses
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/36—Arsenic; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/83—Thymelaeaceae (Mezereum family), e.g. leatherwood or false ohelo
- A61K36/835—Aquilaria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
The invention provides a combustible moxibustion column capable of killing viruses, which is characterized by being prepared from the following raw materials in parts by weight: 20 g of moxa cone, 3 g of sesame oil, 5 g of agilawood and 15 g of realgar. After the moxibustion column is burnt, effective medicinal components are converted into micromolecular nano-scale smoke, and the smoke enters a human body through a respiratory system to kill viruses. The moxibustion column is particularly suitable for killing epidemic encephalitis B virus and novel coronavirus.
Description
Technical Field
The invention relates to the field of medicines, in particular to a combustible moxibustion column capable of killing viruses.
Background
Epidemic encephalitis B virus, abbreviated as Japanese encephalitis virus, is the causative agent of epidemic encephalitis B. The nucleic acid is single-stranded RNA, the outer layer of the nucleic acid is provided with an envelope, and the surface of the envelope is provided with hemagglutinin which can proliferate in animals, chick embryos and tissue culture cells. The piglet is the main infectious source and intermediate host of the encephalitis B virus, and the mosquito is the transmission medium of the encephalitis B virus. When people are bitten by mosquitoes with viruses, the encephalitis B viruses enter the human body, proliferate in phagocytes such as vascular endothelial cells, lymph nodes, liver, spleen and the like, and reach the brain through blood circulation to cause inflammation.
Viruses of the genus coronavirus are enveloped, single-stranded, positive-stranded, linear-genome RNA viruses, and are a large group of viruses widely found in nature. Coronaviruses only infect vertebrates such as humans, mice, pigs, cats, dogs, wolves, chickens, cattle, etc. 2019A novel coronavirus (2019-nCoV, causing novel coronavirus pneumonia COVID-19) is the 7 th known coronavirus capable of infecting people at present, the people are infected with the coronavirus, the common signs of the people comprise respiratory symptoms, fever, cough, shortness of breath, dyspnea and the like, and the novel coronavirus pneumonia is a pandemic disease threatening the health of the people at present because people of all age groups can be infected.
At present, there is no specific treatment method for epidemic encephalitis B caused by epidemic encephalitis B virus and novel coronavirus pneumonia caused by novel coronavirus (2019-nCoV), and therefore, a drug capable of effectively treating the inflammation is urgently needed.
Disclosure of Invention
The invention aims to provide a combustible moxibustion column capable of killing viruses, wherein after the moxibustion column is burnt, effective medicinal components are converted into micromolecular nanoscale smoke, the smoke enters a human body through a respiratory system to kill the viruses, and virus RNA or DNA links are fused, so that the viruses are apoptotic. The invention is particularly suitable for killing epidemic encephalitis B virus and novel coronavirus (2019-nCoV).
The technical scheme of the invention is as follows:
the combustible moxibustion column capable of killing viruses is characterized by being prepared from the following raw materials in parts by weight: 20 g of moxa cone, 3 g of sesame oil, 5 g of agilawood and 15 g of realgar.
The lignum Aquilariae Resinatum and Realgar are all powders.
The invention also provides a preparation method of the combustible moxibustion column, which is characterized by comprising the following steps: mixing lignum Aquilariae Resinatum, Realgar and oleum Sesami, and injecting into moxa cone. Or the agilawood, the realgar and the sesame oil are uniformly mixed and then mixed with the moxa cone raw material to prepare the novel combustible moxa cone.
The combustible moxibustion column can be used for preparing a medicament for preventing and/or treating inflammation caused by coronavirus (especially novel coronavirus 2019-nCoV).
The combustible moxibustion column can also be used for preparing medicines for preventing and/or treating inflammation caused by epidemic encephalitis B virus.
The invention has the beneficial effects that:
the moxibustion column is convenient to apply, special and special medical facilities and professionals are not needed, and the moxibustion column is ignited and placed near a patient only by a relatively closed room, so that the patient inhales gas. After the moxibustion column is ignited, people withdraw and observe through the partition window.
The invention creatively utilizes the high-temperature atomization method to treat virus infected persons, is safer, reduces the toxicity of the medicine, ensures that the medicine is in a small molecular diffusion shape after the moxibustion column is burnt at high temperature, can fully contact with the virus, and more effectively poisons and kills the virus, can quickly kill the virus after the smoke reaches the focus, has large coverage and no dead angle leakage, and is more efficient than any medicine transmitted through blood.
The moxibustion column disclosed by the invention is simple in preparation process, low in cost, convenient to apply and free of side effect, and is the simplest but most miraculous method for killing viruses.
Detailed Description
Example 1
The combustible moxibustion column capable of killing viruses is prepared from the following raw materials in parts by weight: 20 g of moxa cone, 3 g of sesame oil, 5 g of agilawood and 15 g of realgar.
The preparation method of the combustible moxibustion column comprises the following steps: mixing lignum Aquilariae Resinatum, Realgar and oleum Sesami, and injecting into moxa cone.
Example 2
Cases with encephalitis B:
the treatment method comprises the following steps: the patient is placed in a room, the moxibustion column is ignited for fumigation, the fumigation is carried out once a day for the first time of 30 minutes and 20 minutes for the first time, and the fumigation time is shortened sequentially every day.
In 16 years old, the early symptoms of certain female are headache, fever and lethargy, the late symptoms of obnubilation and coma are confirmed to be epidemic encephalitis B by hospitals, the epidemic encephalitis B is fumigated by the moxibustion column described in the embodiment 1, and the epidemic encephalitis B is cured after 6 days and does not relapse.
When a certain plum is 8 years old and a woman suffers from headache, vomiting and fever, the symptom is diagnosed as epidemic encephalitis B in a hospital, and the disease is cured after 5 days by adopting moxibustion columns described in example 1 and is not relapsed to date.
In the case of male, 6 years old, the symptom is headache, vomiting and fever, which is diagnosed as epidemic encephalitis B in hospital, and the disease is cured after 6 days by moxibustion column fumigation as described in example 1, and the disease is not relapsed.
A certain part of moxa for male, 8 years old has symptoms of headache and fever, is diagnosed as epidemic encephalitis B by a hospital, is fumigated by the moxibustion column described in the embodiment 1, is cured after 6 days, and has no recurrence until now.
A certain woman in age 9 has symptoms of headache, vomiting and fever, is diagnosed as epidemic encephalitis B by a hospital, is fumigated by the moxibustion column described in example 1, is cured after 5 days, and has no recurrence until now.
Zheng a certain woman in 10 years old, the symptoms are headache and fever, the disease is diagnosed as epidemic encephalitis B by a hospital, the disease is fumigated by the moxibustion column described in the embodiment 1, and the disease is cured after 5 days, and the disease is not relapsed.
Example 3
The combustible moxibustion column capable of killing viruses is prepared from the following raw materials in parts by weight: 20 g of moxa cone, 3 g of sesame oil, 5 g of agilawood and 15 g of realgar.
The preparation method of the combustible moxibustion column comprises the following steps: the agilawood, the realgar and the sesame oil are uniformly mixed, and then the mixture is mixed with the moxa cone raw material to prepare the novel combustible moxa cone.
The invention is not the best known technology.
The above embodiments are merely illustrative of the technical ideas and features of the present invention, and the purpose thereof is to enable those skilled in the art to understand the contents of the present invention and implement the present invention, and not to limit the protection scope of the present invention. All equivalent changes and modifications made according to the spirit of the present invention should be covered within the protection scope of the present invention.
Claims (6)
1. The combustible moxibustion column capable of killing viruses is characterized by being prepared from the following raw materials in parts by weight: 20 g of moxa cone, 3 g of sesame oil, 5 g of agilawood and 15 g of realgar.
2. The combustible virucidal moxibustion column of claim 1, wherein: the lignum Aquilariae Resinatum and Realgar are all powders.
3. A method for preparing the combustible moxibustion column of claim 1, which is characterized in that: mixing lignum Aquilariae Resinatum, Realgar and oleum Sesami, and injecting into moxa cone.
4. Use of the combustible moxibustion column of claim 1 in the preparation of a medicament for the prevention and/or treatment of inflammation caused by coronavirus.
5. Use according to claim 4, characterized in that: the coronavirus is a novel coronavirus 2019-nCoV.
6. Use of the combustible moxibustion pole of claim 1 in the preparation of a medicament for preventing and/or treating inflammation caused by epidemic encephalitis B virus.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010818411.7A CN112043771A (en) | 2020-08-14 | 2020-08-14 | Combustible moxibustion column capable of killing viruses |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010818411.7A CN112043771A (en) | 2020-08-14 | 2020-08-14 | Combustible moxibustion column capable of killing viruses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112043771A true CN112043771A (en) | 2020-12-08 |
Family
ID=73599042
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010818411.7A Pending CN112043771A (en) | 2020-08-14 | 2020-08-14 | Combustible moxibustion column capable of killing viruses |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112043771A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1876069A (en) * | 2006-04-24 | 2006-12-13 | 赵万友 | Plague preventive oil and method for preparing same |
| CN111134148A (en) * | 2020-02-06 | 2020-05-12 | 宋小冰 | Traditional Chinese medicine aromatherapy air disinfectant |
-
2020
- 2020-08-14 CN CN202010818411.7A patent/CN112043771A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1876069A (en) * | 2006-04-24 | 2006-12-13 | 赵万友 | Plague preventive oil and method for preparing same |
| CN111134148A (en) * | 2020-02-06 | 2020-05-12 | 宋小冰 | Traditional Chinese medicine aromatherapy air disinfectant |
Non-Patent Citations (4)
| Title |
|---|
| 张佳乐等: "艾灸防控新型冠状病毒肺炎的思路探讨", 《医学争鸣》 * |
| 汶川特大地震抗震救灾志 编纂委员会编: "《汶川特大地震抗震救灾志 卷7 灾区医疗防疫志》", 31 August 2015, 北京方志出版社 * |
| 谭兴贵主编: "《中国民间特色疗法》", 31 December 2006, 湖南科学技术出版社 * |
| 齐佳龙等: "基于文献的含挥发性成分中药防治新型冠状病毒肺炎作用探究", 《中医文献杂志》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Aboelsoud | Herbal medicine in ancient Egypt | |
| Teixeira et al. | Comparison of intrarectal ozone, ozone administered in acupoints and meloxicam for postoperative analgesia in bitches undergoing ovariohysterectomy | |
| Qadir | Phage Therapy: a modern tool to control bacterial infections. | |
| Gakuya et al. | Use of ethnoveterinary remedies in the management of foot and mouth disease lesions in a diary herd | |
| Amyes | Magic bullets, lost horizons: the rise and fall of antibiotics | |
| RU2568582C1 (en) | Method for non-specific immunoprophylaxis of bovine respiratory diseases | |
| Freeman-Cook et al. | Staphylococcus aureus infections | |
| CN103735700B (en) | The treatment verminal Medicatedbath lotion of sheep and compound method | |
| CN104288727B (en) | A kind of dedicated compound Chinese medicinal preparation of chill cold in children health care | |
| Allaq et al. | Epidemiological studies of the novel Coronavirus (COVID-19) in Libya | |
| CN103142948A (en) | Medicine for preventing and treating respiratory diseases, and its preparation method | |
| Parascandola | From mercury to miracle drugs: syphilis therapy over the centuries | |
| CN102274355B (en) | Externally applied medicament for treating foot-and-mouth disease in pigs | |
| CN102497878A (en) | Chemical method for sexual sterilisation and libido suppression in male mammals | |
| CN112043771A (en) | Combustible moxibustion column capable of killing viruses | |
| Dahikar et al. | Pharmacokinetics of Withania somnifera (Ashwagandha) in healthy buffalo calves. | |
| CN102755342B (en) | Compound paracetamol injection and preparation method thereof | |
| CN106212542A (en) | A kind of preparation method of veterinary Chinese medicine disinfectant | |
| CN102318648B (en) | Macleaya cordata total alkaloids flea-killing spraying agent | |
| US20220096634A1 (en) | Method of manipulating phages within the body to attack infectious target cells | |
| US20210401876A1 (en) | Pharmaceutical composition of chlorine for treatment of respiratory viral infection | |
| JP2010043057A (en) | Method for exterminating malaria, sleeping sickness, aids and hepatitis c and apparatus therefor | |
| CN101422476A (en) | Animal compound sodium closantel injection | |
| CN105012286A (en) | Use of natural fatty acid disinfectant in preparation of foot and mouth disease virus killing preparation | |
| RU2200580C1 (en) | Method for treating bronchopneumonia in calves |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20201208 |